Sue S. Yom, MD, PhD
Professor, Department of Radiation Oncology, UCSF
Cancer Center Program Memberships
Experimental TherapeuticsResearch Summary
My primary clinical and research interests include head and neck, thoracic, and cutaneous malignancies, where I have developed and led multiple clinical trials, both within UCSF and across sites nationwide and overseas. I am interested in the development and evaluation of new therapeutic techniques, which to me include novel molecular targeted agents and immunotherapies as well as state-of-the-art technical advances in radiation therapy. I have special interests in virally driven malignancies associated with humanpapillomavirus (HPV), Epstein-Barr virus (EBV), and Merkel cell polyomavirus. My research has entailed collaborating with laboratory-based investigators to identify patient, tumor, and technical characteristics that influence prognosis and response to specific therapies, including tissue-, blood-, and imaging-based biomarkers. Other university responsibilities include co-leading the site committees for clinical trial development in cutaneous and head and neck cancers at the UCSF HDFCCC and serving on the Cancer Committee which maintains our accreditation through the American College of Surgeons. Nationally, I have served as the chair of the scientific program and nominating committees for the American Radium Society (ARS), chair of the Appropriateness Committee guidelines for radiation oncology at the American College of Radiology (ACR), and head and neck senior editor at the International Journal for Radiation Oncology Biology Physics (IJROBP). I have been on the scientific program committees of the American Society for Radiation Oncology (ASTRO), the International Association for the Study of Lung Cancer (IASLC), and the American Head and Neck Society (AHNS). I am a member of the NRG Oncology Head and Neck Steering Committee, NCI’s Head and Neck Recurrent/Metastatic Disease Task Force, and the NCCN Head and Neck Cancers guidelines committee. I am a national boards examiner for the American Board of Radiology.Education
2002, University of Pennsylvania, Philadelphia, PA, M.D., Ph.D., Medicine/English
2003, U. T. – M. D. Anderson Cancer Center, Internship, Medicine/Surgery
2007, U. T. – M. D. Anderson Cancer Center, Residency, Radiation Oncology
Professional Experience
-
2007-2013
Assistant Professor of Clinical Radiation Oncology, University of California, San Francisco -
2007-present
Consultant in Radiology, San Francisco Veterans Administration Medical Center -
2008-2013
Assistant Professor in Otolaryngology-Head and Neck Surgery, by courtesy -
2013-present
Professor of Clinical Radiation Oncology, University of California, San Francisco -
2013-present
Professor in Otolaryngology-Head and Neck Surgery, by courtesy
Honors & Awards
- 1992
Mellon Fellow in the Humanities, Andrew W. Mellon Foundation - 1995
Benjamin Franklin Medical Scholar Fellowship, University of Pennsylvania - 2004
Thomas Barkley Award, M. D. Anderson Cancer Center - 2005
Fellowship, Korean American Society for Therapeutic Radiology & Oncology - 2006
Jesse H. Jones Fellowship in Cancer Education, M. D. Anderson Cancer Center - 2006
Outstanding Resident Presentation Award, Texas Radiological Society - 2006
A. Lavoy Moore Endowment Fund, M. D. Anderson Cancer Center - 2006
Eleanor Montague Distinguished Resident Award, American Association of Women Radiologists - 2008
Joan F. Giambalvo Memorial Scholarship, AMA Women Physicians Congress - 2009
Best Doctors in America, 2009-2014 - 2011
Educator of the Year Award, Association of Residents in Radiation Oncology
Selected Publications
- Kearney V, Chan JW, Wang T, Perry A, Yom SS, Solberg TD. Attention-enabled 3D boosted convolutional neural networks for semantic CT segmentation using deep supervision. Phys Med Biol. 2019 Jul 02; 64(13):135001.
View on PubMed - Lee AW, Ng WT, Pan JJ, Chiang CL, Poh SS, Choi HC, Chan Ahn Y, AlHussain H, Corry J, Grau C, Grégoire V, Harrington KJ, Hu CS, Kwong DL, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O'Sullivan B, Ozyar E, Peters LJ, Rosenthal DI, Sanguineti G, Soong YL, Tao Y, Yom SS, Wee JT. International Guideline on Dose Prioritization and Acceptance Criteria in Radiotherapy Planning for Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2019 Jul 02.
View on PubMed - Braverman LC, Yom SS, Zietman AL. Think Carefully, Publish Safely: Co-Authorship and Conflict of Interest Verification in the ASTRO Journals. Int J Radiat Oncol Biol Phys. 2019 Jul 01; 104(3):486-487.
View on PubMed - Strohl MP, Chen JP, Ha PK, Seth R, Yom SS, Heaton CM. Can Early Dental Extractions Reduce Delays in Postoperative Radiation for Patients With Advanced Oral Cavity Carcinoma? J Oral Maxillofac Surg. 2019 May 25.
View on PubMed - Kallianos KG, Muhoozi BN, Gottschalk A, Yom SS, Chan JW, Henry TS, Elicker BM, Ordovas KG, Naeger DM. Dedicated Diagnostic Radiology/Radiation Oncology Rounds: Added Value Beyond Traditional Tumor Boards. Curr Probl Diagn Radiol. 2019 May 09.
View on PubMed - Zietman AL, Yom SS. The Red Journal's Outstanding Reviewers of 2018. Int J Radiat Oncol Biol Phys. 2019 Jul 15; 104(4):703-704.
View on PubMed - de Groot PM, Chung JH, Ackman JB, Berry MF, Carter BW, Colletti PM, Hobbs SB, McComb BL, Movsas B, Tong BC, Walker CM, Yom SS, Kanne JP. ACR Appropriateness Criteria® Noninvasive Clinical Staging of Primary Lung Cancer. J Am Coll Radiol. 2019 May; 16(5S):S184-S195.
View on PubMed - Gay HA, Santiago R, Gil B, Remedios C, Montes PJ, López-Araujo J, Chévere CM, Imbert WS, White J, Arthur DW, Horton JK, Jagsi R, Rabinovich R, Beriwal S, Viswanathan A, Erickson BA, Rengan R, Palma D, Loo BW, Kavanaugh JA, Bradley J, Yom SS, Harari PM, Lee Burnett O. Lessons Learned From Hurricane Maria in Puerto Rico: Practical Measures to Mitigate the Impact of a Catastrophic Natural Disaster on Radiation Oncology Patients. Pract Radiat Oncol. 2019 Apr 15.
View on PubMed - Chan JW, Kearney V, Haaf S, Wu S, Bogdanov M, Reddick M, Dixit N, Sudhyadhom A, Chen J, Yom SS, Solberg TD. A convolutional neural network algorithm for automatic segmentation of head and neck organs at risk using deep lifelong learning. Med Phys. 2019 May; 46(5):2204-2213.
View on PubMed - Yom SS. Integrating the Management of Nodal Metastasis Into the Treatment of Nonmelanoma Skin Cancer. Semin Radiat Oncol. 2019 04; 29(2):171-179.
View on PubMed - Xu MJ, Plonowska KA, Gurman ZR, Humphrey AK, Ha PK, Wang SJ, El-Sayed IH, Heaton CM, George JR, Yom SS, Algazi AP, Ryan WR. Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancer. Laryngoscope. 2019 Mar 27.
View on PubMed - Fakhry C, Zhang Q, Gillison ML, Nguyen-Tân PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM, Barrett WL, Thorstad WL, Yom SS, Wong SJ, Ridge JA, Rao SSD, Spencer S, Fortin A, Raben D, Harris J, Le QT. Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials. Cancer. 2019 Jun 15; 125(12):2027-2038.
View on PubMed - Yom SS, Zietman AL. Jim Cox-The Passing of an Era. Int J Radiat Oncol Biol Phys. 2019 Mar 15; 103(4):783.
View on PubMed - Zietman AL, Yom SS, Braverman LC. Making Sure Retractions Matter. Int J Radiat Oncol Biol Phys. 2019 Apr 01; 103(5):1043-1044.
View on PubMed - Sun L, Chin RI, Gastman B, Thorstad W, Yom SS, Reddy CA, Nussenbaum B, Wang SJ, Knackstedt T, Vidimos AT, Koyfman SA, Manyam BV. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy. JAMA Dermatol. 2019 Feb 27.
View on PubMed - Koyfman SA, Ismaila N, Crook D, D'Cruz A, Rodriguez CP, Sher DJ, Silbermins D, Sturgis EM, Tsue TT, Weiss J, Yom SS, Holsinger FC. Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline. J Clin Oncol. 2019 Feb 27; JCO1801921.
View on PubMed - Chan JW, Yeh I, El-Sayed IH, Algazi AP, Glastonbury CM, Ha PK, Yom SS, van Zante A. Ultraviolet light-related DNA damage mutation signature distinguishes cutaneous from mucosal or other origin for head and neck squamous cell carcinoma of unknown primary site. Head Neck. 2019 Jan 11.
View on PubMed - Wright JL, Yom SS, Awan MJ, Dawes S, Fischer-Valuck B, Kudner R, Mailhot Vega R, Rodrigues G. Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning: An ASTRO Consensus Paper. Pract Radiat Oncol. 2019 Mar; 9(2):65-72.
View on PubMed - Bakst RL, Glastonbury CM, Parvathaneni U, Katabi N, Hu KS, Yom SS. Perineural Invasion and Perineural Tumor Spread in Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2019 Apr 01; 103(5):1109-1124.
View on PubMed - Videtic GM, Paulus R, Singh AK, Chang JY, Parker W, Olivier KR, Timmerman RD, Komaki RR, Urbanic JJ, Stephans KL, Yom SS, Robinson CG, Belani CP, Iyengar P, Ajlouni MI, Gopaul DD, Gomez Suescun JB, McGarry RC, Choy H, Bradley JD. Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2019 Apr 01; 103(5):1077-1084.
View on PubMed